Team finds link between BRCA1 and Ewing sarcoma

March 7, 2018 by Will Sansom, University of Texas Health Science Center at San Antonio

Scientists with the Greehey Children's Cancer Research Institute at UT Health San Antonio have discovered a surprising connection between a breast cancer protein, BRCA1, and a pediatric cancer called Ewing sarcoma.

Their findings, reported March 7 in the journal Nature, reveal a completely new mechanism by which BRCA1 can be rendered dysfunctional. "The observations raise many new questions about both Ewing and BRCA1 biology," said the study's senior author, Alexander J.R. Bishop, D.Phil., of UT Health San Antonio.

Ewing sarcoma is a pediatric bone and . The median age of Ewing sarcoma patients is 15 years, and more than half of patients are adolescents. "Our team worked to identify why Ewing sarcoma is usually sensitive to standard drugs, with the hope of finding new targets for therapy and revealing new ways to treat the disease if it returns or does not respond to standard therapies," Dr. Bishop said.

Fused genes

Almost all Ewing sarcomas are caused by a rearrangement of two genes that are fused together. The resulting combination of the Ewing sarcoma protein, EWSR1, and another protein, usually FLI1, is called a "fusion oncogene." This bad actor promotes cancer.

The researchers reported in Nature that:

  • The mutant protein produced by the fusion oncogene interferes with normal EWSR1 function. Because of this, the cancer's normal cell functions run unchecked.
  • BRCA1, which repairs damaged DNA (genetic material) when those same cell functions shut off, cannot do this repair because the machinery keeps running.

"EWSR1 is like a train conductor who sees damage on the tracks ahead and stops the train," Dr. Bishop said. "BRCA1 is the repair crew who are passengers on the train and go fix the damage when the train stops. But now you've got this mutant bully, this fusion oncogene, who prevents the conductor from being able to stop the train and prevents the repair crew from getting off to work on the tracks."

Explore further: A noncoding RNA promotes pediatric bone cancer

More information: Aparna Gorthi et al, EWS–FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma, Nature (2018). DOI: 10.1038/nature25748

Related Stories

A noncoding RNA promotes pediatric bone cancer

November 17, 2014
Ewing sarcoma is a cancer of bone or its surrounding soft tissue that primarily affects children and young adults. A hallmark of Ewing sarcoma is a translocation event that results in the fusion of an RNA binding protein, ...

Two agents deliver knockout punches to Ewing sarcoma

October 3, 2017
When combined with an already FDA-approved chemotherapy, a novel agent developed by researchers at Georgetown Lombardi Comprehensive Cancer Center, appears to halt the ability of Ewing sarcoma to grow and progress.

Unique research approach finds FDA-approved drug shuts down Ewing sarcoma cells in lab

January 30, 2018
Based on a novel approach to drug discovery, researchers at Georgetown Lombardi Comprehensive Cancer Center say an agent approved to treat a type of leukemia might also help young people with a much rarer and aggressive form ...

Cancer researchers hit a bullseye with new drug target for Ewing sarcoma

January 25, 2018
Screening a class of recently-developed drug compounds—so-called "CDK inhibitors" capable of blocking CDK7/12/13 proteins—against hundreds of different human cancer cell lines, researchers at Dana-Farber/Boston Children's ...

Boosting sarcoma cell death

October 5, 2017
Ewing sarcomas – rare, aggressive childhood cancers – are derived from mesenchymal cells in bone and soft tissues, and children with metastatic disease have poor survival.

Scientists tackle the aberrant epigenetic programming underlying childhood cancers

February 20, 2018
Several childhood cancer cell types show features of immature neural cells, and there is evidence suggesting that these tumors may arise from neural crest stem cells that underwent abnormal changes during embryonic development. ...

Recommended for you

Breast cancer fuelled by mysterious Yin Yang protein

July 23, 2018
Scientists have unveiled clues about a mysterious molecule called Yin Yang1—and revealed it may fuel tumour growth in breast cancer.

Daily low-dose aspirin may be weapon against ovarian cancer

July 20, 2018
(HealthDay)— One low-dose aspirin a day could help women avoid ovarian cancer or boost their survival should it develop, two new studies suggest.

Discovery of kidney cancer driver could lead to new treatment strategy

July 19, 2018
University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change ...

High fruit and vegetable consumption may reduce risk of breast cancer, especially aggressive tumors

July 19, 2018
Women who eat a high amount of fruits and vegetables each day may have a lower risk of breast cancer, especially of aggressive tumors, than those who eat fewer fruits and vegetables, according to a new study led by researchers ...

Sunscreen reduces melanoma risk by 40 per cent in young people

July 19, 2018
A world-first study led by University of Sydney has found that Australians aged 18-40 years who were regular users of sunscreen in childhood reduced their risk of developing melanoma by 40 percent, compared to those who rarely ...

Analysis of prostate tumors reveals clues to cancer's aggressiveness

July 19, 2018
Using genetic sequencing, scientists have revealed the complete DNA makeup of more than 100 aggressive prostate tumors, pinpointing important genetic errors these deadly tumors have in common. The study lays the foundation ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.